Cosmos Health Inc COSM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if COSM is a good fit for your portfolio.
News
-
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share
-
Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders
-
COSMOS HEALTH CEO Issues Letter to Shareholders
-
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company
-
Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market
-
Cosmos Health Announces Relaunch of bio-bebe(R), its Proprietary Organic Infant Care & Nutrition Brand; Aims to Penetrate $103bn Global Baby Food Market
-
Cosmos Health Announces Strategic Collaboration with C.A.PAPAELLINAS Group
-
Cosmos Health Starts Stock Buyback Program
Trading Information
- Previous Close Price
- $1.06
- Day Range
- $1.02–1.08
- 52-Week Range
- $0.97–23.84
- Bid/Ask
- $1.03 / $1.05
- Market Cap
- $14.34 Mil
- Volume/Avg
- 88,672 / 1.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.21
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Core
- Total Number of Employees
- 102
- Website
- https://www.cosmoshold.com
Valuation
|
Metric
|
COSM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.31 |
Price/Sales | 0.21 |
Price/Cash Flow | — |
Price/Earnings
COSM
Financial Strength
|
Metric
|
COSM
|
|---|---|
Quick Ratio | 1.41 |
Current Ratio | 2.06 |
Interest Coverage | −6.96 |
Quick Ratio
COSM
Profitability
|
Metric
|
COSM
|
|---|---|
Return on Assets (Normalized) | −6.48% |
Return on Equity (Normalized) | −11.95% |
Return on Invested Capital (Normalized) | −6.33% |
Return on Assets
COSM
Medical Distribution Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
MCK
| McKesson Corp | Dxfqrvb | $61.4 Bil | |
COR
| Cencora Inc | Wqztgk | $40.1 Bil | |
CAH
| Cardinal Health Inc | Pjmywc | $26.2 Bil | |
SHPMF
| Shanghai Pharmaceuticals Holding Co Ltd Class H | Prb | $8.4 Bil | |
SHPMY
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H | Pybp | $8.4 Bil | |
SHTDY
| Sinopharm Group Co Ltd ADR | Mlmb | $7.9 Bil | |
SHTDF
| Sinopharm Group Co Ltd | Wlc | $7.9 Bil | |
AMFPF
| Amplifon SpA Az nom Post Frazionamento | Tzkcrg | $7.1 Bil | |
MAHLY
| Medipal Holdings Corp ADR | Gqf | $3.3 Bil | |
OMI
| Owens & Minor Inc | Ltm | $1.5 Bil |